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SUMMARY
All patients identified in the neonatal screening programme for congenital hypothyroidism in
Northern Ireland between 1983 and 1993 were reviewed. 131 infants were recalled because of
TSH elevation ofwhom 85 proved to have true permanent congenital hypothyroidism, while 44
had transient TSH elevation and 2 cases died before the diagnosis could be confirmed. TSH
elevation at presentation was milder in the transient group and these infants were more likely to
be unwell and/or suffering from congenital malformation.
INTRODUCTION
Congenital hypothyroidism (CH) is a largely
preventable cause of learning disability.' In the
United Kingdom, neonatal screening for this
condition began in 1978 and by 1982 a national
programme was established. Early results
estimated the incidence at 1 in 3937 live births.2
However, follow-up shows that some infants
have transient abnormalities ofthyroid function
tests which do not require lifelong treatment.
This study was performed to ascertain the
incidenceofpermanentCHandtransientneonatal
abnormalities ofthyroidfunction within aHealth
Service Region from January 1983 to December
1993 and to compare the clinical differences at
presentation between these two groups.
PATIENTS AND METHODS
All infants in Northern Ireland from 1st January
1983 to 31st December 1993 were screened for
congenital hypothyroidism at a recommended
age between 6 and 8 days. Only patients born
before 1994 were included as this allowed
sufficientfollowup, ifnecessaryofftreatment, to
confirm the initial diagnosis. The number oflive
births was determined from the report of the
Registrar General. Screening was performed by
thyroid stimulating hormone (TSH)
measurements fromblood spotsusing Schleicher
andSchuell No. 2992 filterpapercards. TSH was
measuredoverthereportedperiodusingreagents
supplied by Pharmacia UK (1983-1986) and
EG&GWallac DelfiaTM Neonatal hTSH forthe
remaining period. The intra and inter coefficient
ofvariation was <12Y% within the working range
(10-250 mU/l whole blood) of the assays.
A whole blood TSH concentration of.10-25 mu/l
wasconsideredborderlineandasecondscreening
sample requested. Infants with a whole blood
TSH >25 mu/l or a persistent borderline result
were recalled for clinical assessment and venous
bloodsampling. Patients wereconsideredtohave
permanent hypothyroidism if the serum TSH
became abnormal (<5 mu/l) after infancy while
on treatment (indicating poor compliance or a
need for an increase in thyroxine dosage) or if
serum TSH increased to >5 mu/l on withdrawing
treatment after the second birthday.
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Transient elevations in TSH were defined in the
following three circumstances:-
1. apersistentmildlyelevatedwholebloodTSH
>10 mu/l on screening with a serum. TSH <5
mu/l at recall.
2. aserumTSH .5 mu/l atrecall whichreturned
to normal in infancy without treatment.
3. normal thyroid function tests (serum TSH
<Smu/l) over a 6 month period after
withdrawal of treatment.
RESULTS
Tableshowsthenumberoflivebirths andnumber
of positive TSH tests per year with 131 cases
referred during the 11-year period. Two patients
with mildly abnormal thyroid function tests at
birth died in early infancy and could not be
classified. Both were born preterm and one had
Downs Syndrome and congenital heart disease.
Therewerenoknownpatientswithalatediagnosis
missed on neonatal screening during this period.
The incidence of permanent CH from January
1983 to December 1993 inclusive was 28.7 per
10 5livebirthsor 1 in3478livebirths. Theannual
incidence as shown (figure) suggests thatin 1991
and 1992 an unusually large number of babies
with permanent CH were diagnosed. Of the 85
patients with permanent CH, the female to male
ratiowas 2.5:1. Twochildrenwerefromthe same
family,3 hadcongenitalheartdisease(1 ofwhom
also had Downs Syndrome) and 2 were preterm.
At first recall the mean serum free thyroxine was
6.5 pmol/l (median 4.4 pmol/l, range 0.4-23.3
pmol/l) and mean serum TSH 350 mu/l (median
267.5 mu/l, range 11.9-1490 mu/i).
Theincidenceofinfantswithabnormalscreening
tests but subsequently found to have transient
abnormalities was 1 in 6720 live births. Ofthese
patients, 30% had normal TSH concentrations of
<5 mu/I at their first recall, 37% had mildly
elevated serum TSH concentrations during
infancy which returned to normal without
treatment and 33% were started on thyroxine in
infancy whichcould subsequently bewithdrawn.
All 12 infants with a raised blood spot TSH on
screening but normal serum TSH (<5 mu/1) at
recall remained clinically and biochemically
euthyroid at follow-up. Of the 32 patients with
raised serum TSH (.5 mu/i) atrecall, the male to
femaleratiowas 1:1.Fivesiblingsfrom2families
were identified and the mother of another infant
had developed hypothyroidism 1 year earlier.
rABLE
Live births and numbers ofpatients with transient abnormalities ofthyroidfunction andpermanent
CHfor each year 1983-1993.
Year Total Recalled Unclassified Transient Abnormality Permanent
live TSH at recall CH
births
5< mull 25 mul
1983 27,255 11 0 1 3 7
1984 27,693 10 0 4 1 5
1985 27,635 9 0 2 1 6
1986 28,152 9 0 0 2 7
1987 27,865 10 0 1 2 7
1988 27,767 8 0 0 3 5
1989 26,071 11 1 1 0 9
1990 26,499 13 0 0 5 8
1991 26,252 19 0 2 5 12
1992 25,572 15 0 0 4 11
1993 24,909 16 1 1 6 8
1983-1993 295,670 131 2 12 32 85
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Fig. Annual incidence ofpermanent congenital hypothyroidism for each year 1983-1993
Myelomeningocele was present in 6 infants,
congenital heart disease in 4, Downs Syndrome
in 2 and prematurity in 2. Within this group, the
median serum free thyroxine at recall was 19.1
pmol/l (range <2-28.4pmol/l) andmedian serum
TSH was 14.5 mu/l (range <5->320 mu/l).
DISCUSSION
TheestimatedannualincidenceofpermanentCH
from 1983-93 in Northern Ireland was 1:3478
live births, slightly higher than the incidence of
the 1982-1984 survey for England, Wales and
Northern Ireland,2 and 1979-1993 Scottish
review.3 Female preponderance is found in all 3
studies. A small rise in the annual incidence of
permanent CH was observed in this study, but
numbers were small. 33.6% of patients recalled
turned out eventually to have transient disease,
slightly higher than the Scottish figure of 25%.3
The difference may be attributed to the lower
screeningTSHvalueusedtorecallpatients inthe
present review. Approximately one third of this
group had normal serumthyroid function tests at
recall andremained clinically andbiochemically
euthyroidatfollow-up. Theremainingtwo-thirds
ofthis group were more problematic because of
persisting abnormalities of thyroid function at
recall. In retrospect, a risk factor for transient
TSH elevation was present in the majority of
these patients from a history of maternal
hypothyroidism or siblings with transient TSH
elevation, possibly as a result of maternal TSH
receptor-blockingantibodies,4'5DownsSyndrome
and use of iodine either as an antiseptic for
myelomeningocele,6 prematurity 7 or in
radiological investigations of congenital heart
disease.8 High incidence of congenital
malformation associated with transient TSH
elevationhasbeen shown.9Inaddition,compared
to infants with permanent CH, this group had an
equal male to female ratio and a significantly
higherfree thyroxine andlower serumTSH level
at recall.
Allneonates who are startedonthyroxine forCH
and maintain normal thyroid function tests on
follow-up should have theirdiagnosis confirmed
bywithdrawingtreatmentafter2years ofageand
following up thyroid function. As previously
shown 10, 11 this is particularly relevant for ill or
pre-terminfantswithlesssevereabnormalitiesof
thyroid function before thyroxine replacement.
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